Cargando…

Targeted Protein Degradation by Chimeric Small Molecules, PROTACs and SNIPERs

Technologies that induce targeted protein degradation by small molecules have been developed recently. Chimeric small molecules such as Proteolysis Targeting Chimeras (PROTACs) and Specific and Non-genetic IAP-dependent Protein Erasers (SNIPERs), and E3 modulators such as thalidomides, hijack the ce...

Descripción completa

Detalles Bibliográficos
Autores principales:	Naito, Mikihiko, Ohoka, Nobumichi, Shibata, Norihito, Tsukumo, Yoshinori
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2019
Materias:	Chemistry
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6914816/ https://www.ncbi.nlm.nih.gov/pubmed/31921772 http://dx.doi.org/10.3389/fchem.2019.00849

Ejemplares similares

Selective Degradation of Target Proteins by Chimeric Small-Molecular Drugs, PROTACs and SNIPERs
por: Ishikawa, Minoru, et al.
Publicado: (2020)

SNIPER(TACC3) induces cytoplasmic vacuolization and sensitizes cancer cells to Bortezomib
por: Ohoka, Nobumichi, et al.
Publicado: (2017)

Estrogen Receptor-α Targeting: PROTACs, SNIPERs, Peptide-PROTACs, Antibody Conjugated PROTACs and SNIPERs
por: Negi, Arvind, et al.
Publicado: (2022)

Development of a potent small‐molecule degrader against oncogenic BRAF(V600E) protein that evades paradoxical MAPK activation
por: Ohoka, Nobumichi, et al.
Publicado: (2022)

Development of Agonist-Based PROTACs Targeting Liver X Receptor
por: Xu, Hanqiao, et al.
Publicado: (2021)

Development of Rapid and Facile Solid‐Phase Synthesis of PROTACs via a Variety of Binding Styles
por: Xu, Hanqiao, et al.
Publicado: (2022)

Peptide Stapling Improves the Sustainability of a Peptide-Based Chimeric Molecule That Induces Targeted Protein Degradation
por: Yokoo, Hidetomo, et al.
Publicado: (2021)

Targeted Protein Degradation by Chimeric Compounds using Hydrophobic E3 Ligands and Adamantane Moiety
por: Shoda, Takuji, et al.
Publicado: (2020)

Recent advances in IAP-based PROTACs (SNIPERs) as potential therapeutic agents
por: Wang, Chao, et al.
Publicado: (2022)

Targeting Protein Kinases Degradation by PROTACs
por: Yu, Fei, et al.
Publicado: (2021)

Non-small molecule PROTACs (NSM-PROTACs): Protein degradation kaleidoscope
por: Ma, Sinan, et al.
Publicado: (2022)

Development of protein degradation inducers of oncogenic BCR‐ABL protein by conjugation of ABL kinase inhibitors and IAP ligands
por: Shibata, Norihito, et al.
Publicado: (2017)

Light-mediated multi-target protein degradation using arylazopyrazole photoswitchable PROTACs (AP-PROTACs)
por: Zhang, Qisi, et al.
Publicado: (2022)

Pharmacological difference between degrader and inhibitor against oncogenic BCR-ABL kinase
por: Shibata, Norihito, et al.
Publicado: (2018)

Strategies to Reduce the On‐Target Platelet Toxicity of Bcl‐x(L) Inhibitors: PROTACs, SNIPERs and Prodrug‐Based Approaches
por: Negi, Arvind, et al.
Publicado: (2022)

Small molecule PROTACs: an emerging technology for targeted therapy in drug discovery
por: Pei, Haixiang, et al.
Publicado: (2019)

Influence of EGFR-activating mutations on sensitivity to tyrosine kinase inhibitors in a KRAS mutant non-small cell lung cancer cell line
por: Tsukumo, Yoshinori, et al.
Publicado: (2020)

Reversible Covalent PROTACs: Novel and Efficient Targeted Degradation Strategy
por: Yuan, Minghua, et al.
Publicado: (2021)

Proteolysis targeting chimeras (PROTACs) come of age: entering the third decade of targeted protein degradation
por: Bond, Michael J., et al.
Publicado: (2021)

Discovery of small molecule ligands for the von Hippel-Lindau (VHL) E3 ligase and their use as inhibitors and PROTAC degraders
por: Diehl, Claudia J., et al.
Publicado: (2022)

Cancer cell death induced by novel small molecules degrading the TACC3 protein via the ubiquitin–proteasome pathway
por: Ohoka, N, et al.
Publicado: (2014)

Small-molecule PROTAC mediates targeted protein degradation to treat STAT3-dependent epithelial cancer
por: Jin, Jinmei, et al.
Publicado: (2022)

Bromodomain and BET family proteins as epigenetic targets in cancer therapy: their degradation, present drugs, and possible PROTACs
por: Muddassir, Mohd., et al.
Publicado: (2020)

PROTAC targeted protein degraders: the past is prologue
por: Békés, Miklós, et al.
Publicado: (2022)

Small-Molecule PROTACs for Cancer Immunotherapy
por: Liu, Zefan, et al.
Publicado: (2022)

Targeting Oncoproteins for Degradation by Small Molecule-Based Proteolysis-Targeting Chimeras (PROTACs) in Sex Hormone-Dependent Cancers
por: Liu, Li, et al.
Publicado: (2022)

BacPROTACs mediate targeted protein degradation in bacteria
por: Morreale, Francesca E., et al.
Publicado: (2022)

From Conception to Development: Investigating PROTACs Features for Improved Cell Permeability and Successful Protein Degradation
por: Cecchini, Carlotta, et al.
Publicado: (2021)

DeepPROTACs is a deep learning-based targeted degradation predictor for PROTACs
por: Li, Fenglei, et al.
Publicado: (2022)

Degradation of proteins by PROTACs and other strategies
por: Wang, Yang, et al.
Publicado: (2020)

PROTAC: An Effective Targeted Protein Degradation Strategy for Cancer Therapy
por: Qi, Si-Min, et al.
Publicado: (2021)

Major advances in targeted protein degradation: PROTACs, LYTACs, and MADTACs
por: Alabi, Shanique B., et al.
Publicado: (2021)

PROTAC’ing oncoproteins: targeted protein degradation for cancer therapy
por: Kelm, Jeremy M., et al.
Publicado: (2023)

Proteolysis-targeting chimera (PROTAC) for targeted protein degradation and cancer therapy
por: Li, Xin, et al.
Publicado: (2020)

Mutant-selective degradation by BRAF-targeting PROTACs
por: Alabi, Shanique, et al.
Publicado: (2021)

Preparation of the standard cell lines for reference mutations in cancer gene-panels by genome editing in HEK 293 T/17 cells
por: Suzuki, Takayoshi, et al.
Publicado: (2020)

Small-molecule MDM2/X inhibitors and PROTAC degraders for cancer therapy: advances and perspectives
por: Fang, Yuan, et al.
Publicado: (2020)

Targeted mutagenesis: A sniper-like diversity generator in microbial engineering
por: Zheng, Xiang, et al.
Publicado: (2017)

RNA‐PROTACs: Degraders of RNA‐Binding Proteins
por: Ghidini, Alice, et al.
Publicado: (2020)

Targeting mitochondrial degradation by chimeric autophagy-tethering compounds
por: Liu, Zhenqi, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_cvdvualdakairv4pbq9f1u43is